SCHEMBL4386852

SCHEMBL4386852

CNCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6243799 0.67
SCHEMBL7053928 0.67
Dimethylamine SCHEMBL1715992 0.67
SCHEMBL96148 0.67
SCHEMBL24974315 0.67 PRMT3 (0.30)
Hydrochloric Acid SCHEMBL28658437 0.65
Bromide SCHEMBL28667693 0.65
SCHEMBL28224128 0.63
SCHEMBL592710 0.63
SCHEMBL14515628 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004847-B1 OLIGONUCLEOTIDES COMPRISING SIGNALLING PAIRS AND HYDROPHOBIC NUCLEOTIDES, STEMLESS BEACONS, FOR DETECTION OF NUCLEIC ACIDS, METHYLATION STATUS AND MUTANTS OF NUCLEIC ACIDS PENTABASE APS (DK) 2017-05-03 EP disclosed
WO-2017070482-A2 PSMA TARGETED RADIOHALOGENATED UREAS FOR CANCER RADIOTHERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2017-04-27 WO disclosed
EP-3144325-A1 HIGH PURITY HEPARIN AND PRODUCTION METHOD THEREFOR UNIVERSITY OF MIYAZAKI (JP) 2017-03-22 EP disclosed
US-9583455-B2 Semiconductor device RENESAS ELECTRONICS CORPORATION (JP) 2017-02-28 US disclosed
US-9546226-B2 Catalyst for living radical polymerization and polymerization method KYOTO UNIVERSITY (JP) 2017-01-17 US disclosed
US-9460904-B1 Methods, apparatus, and compositions for mass spectrometry GREVING MATTHEW PAUL (US) 2016-10-04 US disclosed
EP-3053985-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME LG Chem, Ltd. (KR) 2016-08-10 EP disclosed
US-20160039822-A1 HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF,AND METHODS OF TREATMENT THEREWITH SIGNAL PHARM LLC (US) 2016-02-11 US disclosed
EP-1714961-B1 INDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2015-12-09 EP disclosed
EP-2899759-A1 Semiconductor device and method of manufacturing the same Renesas Electronics Corporation (JP) 2015-07-29 EP disclosed
US-8440661-B2 Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines SIGNAL PHARMACEUTICALS, LLC (US) 2013-05-14 US disclosed
US-20120108535-A1 2-FLUORINATED RIBOSES AND ARABINOSES AND METHODS OF USE AND SYNTHESIS CORNELL UNIVERSITY (US) 2012-05-03 US disclosed
US-20110133076-A1 TANDEM DIFFERENTIAL MOBILITY SPECTROMETERS AND MASS SPECTROMETER FOR ENHANCED ANALYSIS MILLER RAANAN A 2011-06-09 US disclosed
WO-2011026959-A1 NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-10 WO disclosed
EP-2290013-A2 Methods of making nanosized particles of benzimidazolone pigments Xerox Corporation (US) 2011-03-02 EP disclosed
EP-1367657-B1 Light emitting element and method of making same KOHA CO LTD (JP) 2010-11-03 EP disclosed
WO-2009027855-A1 RAPID ASSESSMENT OF UPPER RESPIRATORY CONDITIONS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2009-03-05 WO disclosed
WO-2008119070-A1 METHODS OF TREATMENT USING SIRT MODULATORS AND COMPOSITIONS CONTAINING SIRT1 MODULATORS TRUSTEES OF BOSTON UNIVERSITY (US) 2008-10-02 WO disclosed
US-7365063-B2 Quinazolinone and benzoxazinone derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2008-04-29 US disclosed
US-7314769-B2 Organometallic complex and light-emitting element containing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-01-01 US disclosed